University of Newcastle (View other jobs from this organisation)
http://www.healthcareer.net.au/
About UON
Built on the principles of equity, excellence and engagement, the University of Newcastle (UON) has a reputation as a world-class institution making an impact within our regions, throughout Australia and across the globe. At just 50 years of age, we are already ranked among the top 3% of universities world-wide and our passion for innovation and discovery will ensure our performance and reputation continues to rise. Being part of a university on the move gives our people the opportunity to really make a mark in their chosen field.
About the role
The School of Biomedical Sciences and Pharmacy is one of the University's most research-intensive schools, currently ranked in the top three in terms of external research funding. This position is based in UON's Priority Research Centre for Healthy Lungs, located at the cutting edge Hunter Medical Research Institute.
Proudly co-funded by the Lung Foundation Australia through the generous donation of the Manchanda family, you will be working with Professor Phil Hansbro, an internationally recognised research leader in the study of respiratory diseases. The focus of the work is on investigating the genomic and epigenetic basis of the development of lung cancer and progression into adenocarcinomas. Key activities will include:
Skills and experience
To be successful in this role, you will have:
Please note: In accordance with the University's Staff Selection Guidelines, your application will be assessed on the selection criteria found at the link below. It is essential that you address each of the criteria to enable the selection committee to properly assess your application and suitability for interview.
Academic Level A - $64,804 to $87,943 per annum, plus an employer superannuation contribution of 9.5%.
Applications close: Monday, 11 July 2016.